Well it certainly appears NP and Mr ODay have a friendly gentlemen's competition. Gilead suddenly wants to put a drug into a subq injection. Happens to have no SAEs so far. Good for HIV patients. NP certainly upped the game by saying cydy will be 10x gilead and saying gilead has a reputation for being late on acquisitions like IMMU. Monotherapy will certainly be the holy grail although it appears to be hiv1 which if I remember there are like 5 levels with 5 being the closest to aids?? More seasoned medical people should probably chime in for a more reputable response. I most likely did not give an appropriate answer but it's a public message board and you take the good with the bad sometimes.